Factors associated with thrombotic and hemorrhagic complications in pediatric liver transplant: A multi-center analysis from the Starzl Network for Excellence in Pediatric Transplantation.


Journal

Pediatric transplantation
ISSN: 1399-3046
Titre abrégé: Pediatr Transplant
Pays: Denmark
ID NLM: 9802574

Informations de publication

Date de publication:
06 2023
Historique:
revised: 20 02 2023
received: 07 10 2022
accepted: 22 03 2023
medline: 17 5 2023
pubmed: 6 4 2023
entrez: 5 4 2023
Statut: ppublish

Résumé

Survival after pediatric liver transplantation (PLT) is negatively impacted by thrombotic and hemorrhagic complications. Limited data exists regarding factors associated with these complications and utilization of anticoagulation. Retrospective review of donor, recipient variables and outcomes from four centers participating in the Starzl Network for Excellence in Pediatric Transplantation. 76 PLT included 39 (51%) technical variant transplants, with mean follow-up 628 ± 193.6 days. Median age/weight at transplant were 59.3 ± 53.8 months and 19.6 ± 17.2 kg. Seven (9.2%) transplants experienced intraoperative hepatic artery thrombosis (iHAT), all successfully corrected. Four HAT recurred postoperatively on POD 1,7,8 and 616. All three portal vein thromboses (PVT) occurred on POD1. Anticoagulation protocols were initiated intraoperatively in 50 and postoperatively in 66 and were active for all thrombotic and hemorrhagic events. Two patients were re-transplanted for HAT. Two patients died without having thrombotic or hemorrhagic complications. iHAT and post-operative HAT were associated with lower hepatic arterial flows. iHAT was associated with donor variant anatomy, reduced allografts and intraoperative blood loss. Intraoperative ultrasound could not predict post-operative HAT nor PVT. Surgeon pre-operative concern regarding the native portal vein correlated with postoperative PVT. Lower hepatic arterial and portal flows, higher estimated blood losses, higher prothrombin time and use of arterial interposition grafts were associated with postoperative hemorrhagic complications. Thrombotic and hemorrhagic complications after pediatric liver transplant remain rare but significant events. Their occurrence can be predicted with pre-operative assessment of donor and recipient vascular anatomy and direct flow measurement but may not be predicted with ultrasound evaluation nor prevented with anticoagulation.

Sections du résumé

BACKGROUND
Survival after pediatric liver transplantation (PLT) is negatively impacted by thrombotic and hemorrhagic complications. Limited data exists regarding factors associated with these complications and utilization of anticoagulation.
METHODS
Retrospective review of donor, recipient variables and outcomes from four centers participating in the Starzl Network for Excellence in Pediatric Transplantation.
RESULTS
76 PLT included 39 (51%) technical variant transplants, with mean follow-up 628 ± 193.6 days. Median age/weight at transplant were 59.3 ± 53.8 months and 19.6 ± 17.2 kg. Seven (9.2%) transplants experienced intraoperative hepatic artery thrombosis (iHAT), all successfully corrected. Four HAT recurred postoperatively on POD 1,7,8 and 616. All three portal vein thromboses (PVT) occurred on POD1. Anticoagulation protocols were initiated intraoperatively in 50 and postoperatively in 66 and were active for all thrombotic and hemorrhagic events. Two patients were re-transplanted for HAT. Two patients died without having thrombotic or hemorrhagic complications. iHAT and post-operative HAT were associated with lower hepatic arterial flows. iHAT was associated with donor variant anatomy, reduced allografts and intraoperative blood loss. Intraoperative ultrasound could not predict post-operative HAT nor PVT. Surgeon pre-operative concern regarding the native portal vein correlated with postoperative PVT. Lower hepatic arterial and portal flows, higher estimated blood losses, higher prothrombin time and use of arterial interposition grafts were associated with postoperative hemorrhagic complications.
CONCLUSIONS
Thrombotic and hemorrhagic complications after pediatric liver transplant remain rare but significant events. Their occurrence can be predicted with pre-operative assessment of donor and recipient vascular anatomy and direct flow measurement but may not be predicted with ultrasound evaluation nor prevented with anticoagulation.

Identifiants

pubmed: 37016507
doi: 10.1111/petr.14521
doi:

Substances chimiques

Anticoagulants 0

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14521

Informations de copyright

© 2023 Wiley Periodicals LLC.

Références

Oh C-K, Pelletier SJ, Sawyer RG, et al. Uni- and multivariate analysis of risk factors for early and late hepatic artery thrombosis after liver transplantation. Transplantation. 2001;71:767-772.
Langnas AN, Majuro W, Stratta RJ, Wood RP, Shaw BW Jr. Vascular complications after orthotopic liver transplantation. Am J Surg. 1991;161:76-83.
Seda-Neto J, Antunes da Fonseca E, Pugliese R, et al. Twenty years of experience in pediatric living donor liver transplantation: focus on hepatic artery reconstruction, complications, and outcomes. Transplantation. 2016;100:1066-1072.
Seda Neto J, Fonseca EA, Feier F, et al. Analysis of factors associated with portal vein thrombosis in pediatric living donor liver transplant recipients. Liver Transpl. 2014;20:1157-1167.
Sieders E, Peeters PMJ, TenVergert EM, et al. Early vascular complications after pediatric liver transplantation. Liver Transpl. 2000;6:326-332.
Bekker J, Ploem S, de Jong KP. Early hepatic artery thrombosis after liver transplantation: a systematic review of the incidence, outcome and risk factors. Am J Transplant. 2009;9(4):746-757. doi:10.1111/j.1600-6143.2008.02541.x
Borst AJ, Sudan DL, Wang LA, Neuss MJ, Rothman JA, Ortel TL. Bleeding and thrombotic complications of pediatric liver transplant. Pediatr Blood Cancer. 2018;65(5):e26955. doi:10.1002/pbc.26955
Soltys KA, Mazariegos GV, Squires RH, et al. Late graft loss or death in pediatric liver transplantation: an analysis of the SPLIT database. Am J Transplant. 2007;7(9):2165-2171. doi:10.1111/j.1600-6143.2007.01893.x
Elisofon SA, Magee JC, Ng VL, et al. Society of pediatric liver transplantation: current registry status 2011-2018. Pediatr Transplant. 2020;24:e13605. doi:10.1111/petr.1360
Ziaziaris WA, Darani A, Holland AJA, et al. Reducing the incidence of hepatic artery thrombosis in pediatric liver transplantation: effect of microvascular techniques and a customized anticoagulation protocol. Pediatr Transplant. 2017;21(4):1-7. doi:10.1111/petr.12917. Epub 2017 Mar 22. PMID: 28332273.
Ooi CY, Brandão LR, Zolpys L, et al. Thrombotic events after pediatric liver transplantation. Pediatr Transplant. 2010;14:476-482.
Flynn E, Huang JY, Hardikar W, Herd L, Hodgson A, Monagle P. Antithrombotic management and thrombosis rates in children post-liver transplantation: a case series and literature review. Pediatr Transplant. 2019;23(4):e13420. doi:10.1111/petr.13420
Heffron TG, Welch D, Pillen T, et al. Low incidence of hepatic artery thrombosis after pediatric liver transplantation without the use of intraoperative microscope or parenteral anticoagulation. Pediatr Transplant. 2005;9:486-490.
Voulgarelis S, Vitola B, Lerret SM, Hong JC, Scott JP. Perioperative anticoagulation practices for pediatric liver transplantation. Pediatr Transplant. 2018;22(4):e13193. doi:10.1111/petr.13193
Calinescu AM, Karam O, Wilde JCH, Ansari M, McLin VA, Wildhaber BE. International survey on anticoagulation and antiplatelet strategies after pediatric liver transplantation. Pediatr Transplant. 2019;23(1):e13317. doi:10.1111/petr.13317
Bueno J, Escartín A, Balsells J, Margarit C. Intraoperative flow measurement of native liver and allograft during orthotopic liver transplantation in children. Transplant Proc. 2007;39(7):2278-2279. doi:10.1016/j.transproceed.2007.07.042
Spitzer AL, Dick AA, Bakthavatsalam R, et al. Intraoperative portal vein blood flow predicts allograft and patient survival following liver transplantation. HPB (Oxford). 2010;12(3):166-173. doi:10.1111/j.1477-2574.2009.00137.x
Molmenti EP, Levy MF, Molmenti H, et al. Correlation between intraoperative blood flows and hepatic artery strictures in liver transplantation. Liver Transpl. 2002;8(2):160-163. doi:10.1053/jlts.2002.30886
Gu L, Fang H, Li F, Zhang S, Shen C, Han L. Impact of hepatic arterial hemodynamics in predicting early hepatic arterial thrombosis in pediatric recipients younger than three yr after living donor liver transplantation. Pediatr Transplant. 2015;19(3):273-278. doi:10.1111/petr.12444
Nacoti M, Cazzaniga S, Lorusso F, et al. The impact of perioperative transfusion of blood products on survival after pediatric liver transplantation. Pediatr Transplant. 2012;16:357-366.
Mazzaferro V, Esquivel CO, Makowa L, et al. Hepatic artery thrombosis after pediatric liver transplantation - a medical or surgical event? Transplantation. 1998;47(6):9771-9777.
Lewis JH, Bontempo FA, Ragni MV, Starzl TE. Antithrombin III during liver transplantation. Transplant Proc. 1989;21(3):3543-3544. PMID: 2662520; PMCID: PMC2952525.
Sato Y, Nakatsuka H, Yamamoto S, et al. Coagulation and fibrinolytic systems during liver regeneration in the early period after adult living related partial liver transplantation. Transplant Proc. 2008;40(8):2501-2502. doi:10.1016/j.transproceed.2008.08.050
Lisman T, Bakhtiari K, Pereboom IT, Hendriks HG, Meijers JC, Porte RJ. Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests. J Hepatol. 2010;52(3):355-361. doi:10.1016/j.jhep.2009.12.001
Stine JG, Northup PG. Coagulopathy before and after liver transplantation: from the hepatic to the systemic circulatory systems. Clin Liver Dis. 2017;21(2):253-274. doi:10.1016/j.cld.2016.12.003
Stahl RL, Duncan A, Hooks MA, Henderson JM, Millikan WJ, Warren WD. A hypercoagulable state follows orthotopic liver transplantation. Hepatology. 1990;12(3 Pt 1):553-558. doi:10.1002/hep.1840120317
Arshad F, Lisman T, Porte RJ. Hypercoagulability as a contributor to thrombotic complications in the liver transplant recipient. Liver Int. 2013;33(6):820-827. doi:10.1111/liv.12140
Lemoine CP, Brandt KA, Mohammad S, Bhat R, Superina R. Early thrombotic and hemorrhagic complications associated with a risk-adjusted postoperative anticoagulation protocol after pediatric liver transplantation. Pediatr Blood Cancer. 2022;69(10):e29898. doi:10.1002/pbc.29898
Squires JE, Logan B, Lorts A, et al. A learning health network for pediatric liver transplantation: inaugural meeting report from the Starzl network for excellence in pediatric transplantation. Pediatr Transplant. 2019;23(6):e13528. doi:10.1111/petr.13528
Perito ER, Squires JE, Bray D, et al. A learning health system for pediatric liver transplant: the Starzl network for excellence in pediatric transplantation. J Pediatr Gastroenterol Nutr. 2021;72(3):417-424. doi:10.1097/MPG.0000000000002974

Auteurs

Kyle Soltys (K)

Thomas E Starzl Transplant Institute, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Caroline Lemoine (C)

Transplant/Pediatric Surgery, Ann & Robert H. Lurie Childrens Hospital of Chicago, Chicago, Illinois, USA.

Xingyu Zhang (X)

University of Pittsburgh Thomas E Starzl Transplantation Institute, Pittsburgh, Pennsylvania, USA.

Rukhmi Bhat (R)

Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

John Bucuvalas (J)

Pediatric Hepatology, Mount Sinai Hospital Recanati/Miller Transplantation Institute, New York City, New York, USA.
Mount Sinai School of Medicine, New York City, New York, USA.

Sara Rasmussen (S)

Transplantation, Seattle Children's Hospital, Seattle, Washington, USA.

Rene Romero (R)

Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.

Irini Batsis (I)

Pediatric Hepatology, Mount Sinai Hospital Recanati/Miller Transplantation Institute, New York City, New York, USA.
Mount Sinai School of Medicine, New York City, New York, USA.

Blayne Sayed (B)

Surgery, University of Toronto, Toronto, Ontario, Canada.

John Tunno (J)

Patient and Family Voice, Starzl Network for Excellence in Pediatric Transplantation, Pittsburgh, Pennsylvania, USA.

Cassandra Confair (C)

Patient and Family Voice, Starzl Network for Excellence in Pediatric Transplantation, Pittsburgh, Pennsylvania, USA.

Sarah Vargas (S)

Patient and Family Voice, Starzl Network for Excellence in Pediatric Transplantation, Pittsburgh, Pennsylvania, USA.

Riccardo Superina (R)

Transplant/Pediatric Surgery, Ann & Robert H. Lurie Childrens Hospital of Chicago, Chicago, Illinois, USA.

George Mazariegos (G)

Thomas E Starzl Transplant Institute, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH